Veterinary injectable 2% lidocaine for convenient and legal use in cats and dogs
Lidocanit Vet belongs to the group of local anesthetics of the amide type.
Its mechanism of action is based on a decrease in the permeability of the cell membrane to sodium ions, as well as to potassium ions in higher concentrations. As a result, the rate of depolarization decreases and the
excitation threshold increases, leading to reversible local numbness. Lidocaine has local and systemic properties. The local effect is expressed in a decrease in pain and other types of sensitivity, vasodilation and decreased motor function. The systemic effect is usually observed with the administration of large dosages of the veterinary drug and intravenous infusion and consists of manifestations of generalized membrane stabilization (antiarrhythmic effect).
It has a rapid onset of action (about 1 minute after an intravenous administration and 15 minutes
after an intramuscular administration), spreads rapidly into surrounding tissues.
Lidocanit Vet is used in cats and dogs for all types of anesthesia:
Lidocain Vet is also used as an antiarrhythmic agent for ventricular fibrillation.
|
Indication |
Dogs |
Cats |
|
Dosage |
||
|
During local (terminal and infiltration regional anesthesia (conductive, plexus (nerve plexuses)) |
0.2-0.3 ml per 1 kg of body weight (4-6 mg lidocaine hydrochloride per 1 kg of animal body weight) |
0.1-0.2 ml per 1 kg of body weight (2-4 mg lidocaine hydrochloride per 1 kg of animal body weight) |
|
During epidural anesthesia |
0.15-0.2 ml per 1 kg of body weight (3-4 mg lidocaine hydrochloride per 1 kg of animal body weight), as a 1-2% solution |
|
|
During castration and sterilization for infiltration anesthesia |
0.1 ml per 1 kg of body weight (2 mg lidocaine hydrochloride per 1 kg of animal body weight) |
|
|
For analgesia (as a multimodal anesthesia for long-term surgical interventions, including abdominal surgery, osteosynthesis and others, as well as symptomatic therapy for abdominal pain of various origins) |
Intravenously 25-35 mcg/kg/min of lidocaine (no more than 50 micrograms/kg/min) |
Intravenously 15-25 mcg/kg/min of lidocaine |
|
When relieving ventricular arrhythmias, including ventricular fibrillation |
Slowly intravenously as a 1% solution at a dose of 0.1 ml per 1 kg of animal body weight (2 mg lidocaine hydrochloride per 1 kg of animal body weight) |
Slowly intravenously at a dose of 0.1 ml per 1 kg of animal body weight (2 mg lidocaine hydrochloride per 1 kg of animal body weight) |
|
During tracheal intubation for superficial anesthesia of the laryngeal fissure |
Used by irrigation at a dose of 0.2 ml of the drug per procedure |
|
If it is necessary to reduce the concentration of lidocaine to up to 1%, it is possible to dilute lidocaine to up to 0.9% of saline solution. The volume of the injected solution depends on the type of anesthesia, body weight of the animal, degree of anesthesia and is determined by a veterinarian. The total daily dosage of lidocaine in a combination of various methods of analgesia and anesthesia should not exceed 4 mg/kg for cats and 7 mg/kg for dogs. During analgesia, intravenous lidocaine is administered by infusion at a constant rate with mandatory dilution in 0.9% saline solution. The required dose of lidocaine and the volume of dilution are calculated taking into account the body weight of the animal and the duration of administration of the drug according to the supervision of a veterinarian. The treatment course in case of pain of various origins is determined by a veterinarian individually, depending on the severity of the pain syndrome, the severity of the disease and the condition of the animal.
Contraindications and special instructions:
Individual hypersensitivity of animals to the components of the drug and to amide-type anesthetics.
Severe sinoatrial block, sinus node dysfunction syndrome, 3rd degree atrioventricular (AV) block, severe intraventricular conduction disorders, paroxysmal supraventricular tachycardia (WPW syndrome).
Cardiogenic or hypovolemic shock, acute decompensation of heart failure.
For subarachnoid anesthesia - complete heart block, bleeding, arterial hypotension, shock, infection of the lumbar puncture site, septicemia, as well as renal failure, gastric and duodenal ulcer, hypercorticism (Cushing's syndrome), diabetes mellitus, osteoporosis, predisposition to thromboembolism, severe arterial hypertension, viral diseases.
In females during pregnancy, the veterinary drug should be used with caution under the supervision of a veterinarian.
